Navigation Links
Biostar Pharmaceuticals, Inc. Begins Assembly of New Production Line
Date:5/25/2010

XIANYANG, China, May 25 /PRNewswire-Asia-FirstCall/ -- Biostar Pharmaceuticals, Inc. (Nasdaq: BSPM) ("Biostar" or "the Company"), the Xianyang-based manufacturer of a leading over-the-counter Hepatitis B medicine, Xin Aoxing Oleanolic Acid Capsule ("Xin Aoxing"), and a variety of pharmaceutical products and medical nutrients, today announced that it has commenced assembly of its production line for its proprietary Zushima product.

Biostar completed Chinese Military Drug Administration clinical trials for Zushima Analgesic Aerosol Spray ("Zushima") in April through the Chinese No. 4 Military Medical University. Zushima is a traditional Chinese herbal product used to relieve pain through a topical application to affected areas or closed wounds. Zushima spray can also be used in the treatment of certain rheumatic conditions. The product was classified as "Specially Needed Drug" by the Chinese Military Drug Administration, which will also be available to the public.

Biostar commenced assembly of its production line for Zushima on April 28, 2010 and intends to complete construction in early August, which will have an annual capacity of $30.0 million. $0.7 million was budgeted for the production line equipment used at the Company's Xianyang-based facilities. Upon completion, Biostar plans to obtain formal approval from the Military Food and Drug Administration and a Good Manufacturing Process (GMP) certification, which the company expects to receive by September 2010. This will enable a formal launch of Zushima to the Chinese military, civil hospitals and pharmacies in
'/>"/>

SOURCE Biostar Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Inverness Medical Innovations to Close Cholestech, HemoSense and BioStar Facilities
2. Biostar Pharmaceuticals, Inc. Reports Record Revenues and Earnings for 2008
3. Biostar Pharmaceuticals, Inc. Reports Continued Revenues and Earnings Growth in First Quarter of 2009
4. Biostar Pharmaceuticals, Inc. Retains HC International, Inc. to Implement Investor Relations Program
5. Biostar Pharmaceuticals, Inc. to Host Fiscal Year 2009 Second Quarter Earnings Conference Call on Friday, August 14, 2009 at 10:30 a.m. EDT
6. Biostar Pharmaceuticals, Inc. Announces Second Quarter 2009 Financial Results
7. Biostar Pharmaceuticals, Inc. to Launch Xin Aoxing Oleanolic Acid Capsules in Beijing and Shanghai
8. Biostar Pharmaceuticals, Inc. Announces First Quarter 2010 Financial Results
9. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
10. Prestwick Pharmaceuticals, Inc. Continues to Build Management Team With Appointment of Martin Stogniew, Ph.D. as Executive Vice President, Chief Technology Officer
11. Keryx Biopharmaceuticals, Inc. Announces Appointment of Michael P. Tarnok to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... overlooked factor in the medical application of nanoparticles. ... on both radiofrequency heating and magnetic resonance image ... including detailed analysis of the aggregate morphologies based ... produce significant reductions in both heating and MRI ... quantify and correlate these effects for clinical applications, ...
(Date:9/2/2014)... 2, 2014 Persistence Market Research ... in Pharmaceutical, Biopharma and Life Sciences: North ... the global membrane technology market for pharmaceutical, biopharma and life sciences ... is expected to grow at a CAGR of 9.1% ... of USD 10,886.0 million in 2019. Browse ...
(Date:9/2/2014)... Sept. 2, 2014 Orexigen Therapeutics, Inc. (Nasdaq: ... Patent and Trademark Office (PTO) has issued a patent ... for weight loss. NB32 is a fixed-dose combination of ... U.S. Patent No. 8,815,889 claims methods for treating insulin ... patent expires in 2024. If NB32 is approved for ...
(Date:9/2/2014)... Mount, NC (PRWEB) September 02, 2014 ... establishment of its 11th clinical research site: PMG Research ... assumed ownership and operation of the clinical research department ... further expanding PMG’s presence in eastern North Carolina. This ... patients. For the patients in Rocky Mount and the ...
Breaking Biology Technology:Accounting for biological aggregation in heating and imaging of magnetic nanoparticles 2Global Membrane Technology Market Will Reach $10,886.0 Million in 2019: Persistence Market Research 2Global Membrane Technology Market Will Reach $10,886.0 Million in 2019: Persistence Market Research 3Global Membrane Technology Market Will Reach $10,886.0 Million in 2019: Persistence Market Research 4Global Membrane Technology Market Will Reach $10,886.0 Million in 2019: Persistence Market Research 5Orexigen Expands NB32 Intellectual Property Portfolio With New U.S. Patent 2Orexigen Expands NB32 Intellectual Property Portfolio With New U.S. Patent 3Orexigen Expands NB32 Intellectual Property Portfolio With New U.S. Patent 4PMG Research Announces the Formation of its Eleventh Site 2PMG Research Announces the Formation of its Eleventh Site 3
... Wis . - Can a heart patient's own stem cells be ... School of Medicine and Public Health intends to find out ... Hospital and Clinics . , ,The school is among the first ... which will investigate whether a person's own stem cells can treat ...
... - Deltanoid Pharmaceuticals , a privately held pharmaceutical ... clinical study of 2MD, its lead osteoporosis compound. , ... can safely improve bone mineral density in postmenopausal women. ... bone that results in susceptibility to fractures, occurs frequently ...
... - In a recent report that probably went ... University Technology Managers released figures that show why ... Wisconsin is a hotbed for scientific research. The numbers ... professors working in labs; it's about creating jobs for ...
Cached Biology Technology:UW tests adult stem cell role in regenerative heart care 2Tapping hidden assets: Wisconsin researchers who can create jobs 2Tapping hidden assets: Wisconsin researchers who can create jobs 3Tapping hidden assets: Wisconsin researchers who can create jobs 4
(Date:9/2/2014)... Human Genetics (ASHG) and the National Human Genome ... of Health, have named Elizabeth P. Tuck, MA, ... in Columbus, Ohio, the first ASHG/NHGRI Genetics and ... The Genetics and Education Fellowship is intended to ... and network to prepare for a career in ...
(Date:9/2/2014)... -- A team of University of Maryland physicists ... other scientists say make possible new nanostructures and ... energy and quantum computing advances to new sensor ... of Nature Communications the Maryland scientists, ... for hybrid nanostructures that uses a connector, or ...
(Date:9/2/2014)... new study that could ultimately lead to many new ... Research Institute (TSRI) have adapted a chemical approach to ... that can treat a form of muscular dystrophy. , ... a disease-causing defect as a catalyst to synthesize a ... Disney.,"Because the treatment is synthesized only in diseased cells, ...
Breaking Biology News(10 mins):ASHG and NHGRI award first genetics and education fellowship 2New synthesis method may shape future of nanostructures, clean energy 2New synthesis method may shape future of nanostructures, clean energy 3Scripps Florida scientists make diseased cells synthesize their own drug 2
... More atomic hydrogen gas the ultimate fuel for stars ... astronomer Dr Robert Braun has found.,This is the first accurate ... Just after the Big Bang the Universe,s matter was ... came together and generated galaxies, stars and planets and ...
... Agricultural Research and Development, have evaluated the effect of ... in sheep flocks. This disease mainly causes abortions, although ... and weakness in newborn lambs. The control of this ... it spreads easily among the animals and causes significant ...
... be held in Copenhagen, Denmark, on 4-5 June, ... the GMES Global Monitoring for Environment and Security ... User testimonials of pre-operational services, prospects for increased ... assessments will form the core of the conference ...
Cached Biology News:There's more star-stuff out there but it's not dark matter 2The effect of treatment with antibiotics and vaccination against Q fever in sheep 2The effect of treatment with antibiotics and vaccination against Q fever in sheep 3
... is a simple, easy to use ... bacterial and yeast applications. The ... voltages and either one mm, two ... pressing the pulse button the electroporator ...
... CGH Genomic Labeling Systems are a high-performance ... genomic DNA samples for array-based Comparative Genomic ... direct labeling formats, the BioPrime Plus Array ... solution to your genomic labeling needs. ...
MOUSE ANTI GTP BINDING PROTEIN...
The Cellject Elecroporator is suitable for all cell types including embryo, mammalian, plant, yeast and bacterial. Its has highly user-freindly programing and can be used remotely, for example in a l...
Biology Products: